News | Hypertension | November 13, 2018

Hypertensive Crisis Five Times More Likely Among Blacks

Nearly 90 percent of patients experiencing dangerous blood pressure spikes in inner-city study were black

Hypertensive Crisis Five Times More Likely Among Blacks, according to a late-breaking study at AHA 2018. #AHA #AHA18 #AHA2018

November 13, 2018 — Black adults experience dangerous spikes in high blood pressure, called a hypertensive crisis, at a rate that is five times the national average, according to a new study. The study was presented at the American Heart Association’s (AHA) Joint Hypertension 2018 Scientific Sessions, an annual conference focused on recent advances in hypertension research, Sept. 6-9 in Chicago.

Hypertensive crisis is a complication of high blood pressure in which blood pressure quickly and severely soars to life-threatening levels. People often can avoid this dangerous blood pressure escalation by keeping their blood pressure under control with medications and lifestyle modifications.

“We studied an inner-city population to find that being black is a risk factor for progressing from hypertension to hypertensive crisis,” said study author Frederick A. Waldron, M.D., M.P.H., M.S., an emergency medicine physician at Newark Beth Israel Medical Center, Newark, N.J. “Now that we have effective antihypertensive medications available, hypertensive crisis and hypertensive emergency, a rare but further progression of hypertensive crisis in which organ damage occurs, should not exist to this degree among black or other patients.”

In what Waldron said is the largest case control study to date on hypertensive crisis patients, researchers looked back at emergency department medical records of more than 15,000 patients from 2013 to 2016. They defined hypertensive crisis as blood pressure at or above 200/120 mmHg and found:

  • Nearly 1,800, or 11.4 percent, of the 15,631 hypertensive patients that came through the emergency department in the three-year study were in hypertensive crisis;
  • Nearly 90 percent of those in hypertensive crisis were black.;
  • One in four, or 25 percent, of patients with hypertensive crisis went on to develop catastrophic organ failure, including stroke, congestive heart failure, kidney failure or heart attack;
  • Being older than 65 years or male, as well as having anemia, chronic kidney disease or a history of stroke and cardiovascular diseases, including high cholesterol, predicted higher risk for hypertensive emergencies. Anemia has not been identified before as a hypertensive emergency risk factor, according to Waldron; and
  • Insurance status and access to primary care did not affect patients’ odds of having a hypertensive crisis.

“There is no good treatment for organ damage, so the best way to address this is to develop a preventative strategy,” Waldron said. He suggested efforts to help patients take their medicine properly could help reduce hypertensive crises.

The numbers in the study may be underestimated due to differing definitions of hypertensive crisis. For example, the American Heart Association defines it as blood pressures at or above 180/120 mmHg. This study defined hypertensive crisis as above 200/120. Waldron said future studies should determine rate of adherence to blood pressure medications and follow patients in hypertensive crisis longer to determine true hypertension emergency incidence.

The study’s co-author is Irina Benenson, D.N.P., F.N.P.-C, R.N. Author disclosures are on the abstract.

Watch the related VIDEO: Reducing Hypertension Among African-Americans — an interview with Kim Allan Williams, Sr., M.D., chief of the Division of Cardiology and the James B. Herrick Professor at Rush University Medical Center. He discusses the efforts being made by the Association of Black Cardiologists to reduce systemic hypertension in the African-American community. Williams is speaking on this topic at the American Heart Association 2018 meeting.

For more information: www.professional.heart.org


Related Content

News | Hypertension

Sept. 04, 2025 — CorVista Health has published a new case series in the Journal of the American College of Cardiology ...

Home September 09, 2025
Home
News | Hypertension

Sept. 5, 2025 — Idorsia Ltd has announced a first-of-its-kind initiative with the Stanford Hypertension Center and Duke ...

Home September 08, 2025
Home
News | Hypertension

Aug. 19, 2025 — Idorsia Ltd recently announced its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan ...

Home August 27, 2025
Home
News | Hypertension

May 19, 2025 — Gradient Denervation Technologies recently announced the company’s pulmonary denervation system has ...

Home May 20, 2025
Home
News | Hypertension

April 9, 2025 — Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released ...

Home April 09, 2025
Home
News | Hypertension

Mar. 10, 2025-- Corcept Therapeutics Inc., a commercial-stage company engaged in the discovery and development of ...

Home March 11, 2025
Home
News | Hypertension

Jan. 9, 2025 — Gender-based racism through microaggressions may be linked to higher blood pressure postpartum and beyond ...

Home January 14, 2025
Home
News | Hypertension

Jan. 8, 2025 — Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines ...

Home January 08, 2025
Home
News | Hypertension

Dec. 11, 2024 — Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking ...

Home December 19, 2024
Home
News | Hypertension

June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...

Home June 28, 2024
Home
Subscribe Now